Opportunities to assess factors contributing to the development of the intestinal microbiota in infants living in developing countries

Dennis Lang, MAL-ED Network Investigators, Dennis Lang, MAL-ED Network Investigators

Abstract

Recent evidence suggests that establishment of a healthy gut microbiota shortly after birth is important to achieve optimal growth and development of children. Being born into a resource-poor environment presents challenges to the establishment of a healthy gut microbial flora in the newborn. Among these challenges are births that occur at home, traditional pre-lacteal feeding of newborns leading to failure to initiate lactation, poor sanitation and water quality, early environmental exposure to, and infection with, enteric or other pathogens, suboptimal breast feeding duration and intensity, deficiencies in weaning and childhood diets contributing to micro- and macro-nutrient deficiencies, and the frequent use of antibiotics. These factors should be considered in the design and implementation of preventive and therapeutic interventions aimed at improving the health and development of these children.

Keywords: child development; developing countries; enteric infections; environmental enteropathy; gut microbiota; probiotics; under-nutrition.

Figures

Fig. 1
Fig. 1
Proportion of children stunted during the first two years at MAL-ED sites. Each child was measured every month for the first two years. Green – proportion of children not stunted (>−2 LAZ), Orange – proportion of children stunted (−3 LAZ), Blue – proportion of children severely stunted (

Fig. 2

The number of births occurring…

Fig. 2

The number of births occurring at home and at a medical facility in…

Fig. 2
The number of births occurring at home and at a medical facility in each of the MAL-ED sites.

Fig. 3

Decrease in exclusive breastfeeding at…

Fig. 3

Decrease in exclusive breastfeeding at MAL-ED Sites. Survival curves of exclusive breastfeeding are…

Fig. 3
Decrease in exclusive breastfeeding at MAL-ED Sites. Survival curves of exclusive breastfeeding are shown for each of the MAL-ED sites. Exclusive breastfeeding is defined as only having received colostrum and breast milk until such time as other liquids such as water, tea, solids are given.

Fig. 4

(a) Proportion of cohort children…

Fig. 4

(a) Proportion of cohort children at each MAL-ED site that have been infected…

Fig. 4
(a) Proportion of cohort children at each MAL-ED site that have been infected with at least one enteric pathogen. (b) Proportion of cohort children at each MAL-ED site that has experienced at least one diarrhea episode.

Fig. 5

Percent of normal stool samples…

Fig. 5

Percent of normal stool samples containing at least one enteric pathogen. Normal stool…

Fig. 5
Percent of normal stool samples containing at least one enteric pathogen. Normal stool samples were collected monthly and assayed for all enteric pathogens including bacteria, viruses, and parasites studied in MAL-ED. In the case of norovirus a subset of 10% of subjects were randomly selected from each site to have their normal stool samples assayed. The results for each site are shown as different colors indicated in the legend at the right of the figure.

Fig. 6

(a) Percentage of days during…

Fig. 6

(a) Percentage of days during the first two years of life that cohort…

Fig. 6
(a) Percentage of days during the first two years of life that cohort children at each MAL-ED site received or did not receive antibiotics. (b) Treatment of diarrhea episodes with antibiotics at each MAL-ED site. Gray bars represent the percent of diarrhea episodes for which antibiotics were given. Black hash marks indicate the average number of antibiotics given.
Fig. 2
Fig. 2
The number of births occurring at home and at a medical facility in each of the MAL-ED sites.
Fig. 3
Fig. 3
Decrease in exclusive breastfeeding at MAL-ED Sites. Survival curves of exclusive breastfeeding are shown for each of the MAL-ED sites. Exclusive breastfeeding is defined as only having received colostrum and breast milk until such time as other liquids such as water, tea, solids are given.
Fig. 4
Fig. 4
(a) Proportion of cohort children at each MAL-ED site that have been infected with at least one enteric pathogen. (b) Proportion of cohort children at each MAL-ED site that has experienced at least one diarrhea episode.
Fig. 5
Fig. 5
Percent of normal stool samples containing at least one enteric pathogen. Normal stool samples were collected monthly and assayed for all enteric pathogens including bacteria, viruses, and parasites studied in MAL-ED. In the case of norovirus a subset of 10% of subjects were randomly selected from each site to have their normal stool samples assayed. The results for each site are shown as different colors indicated in the legend at the right of the figure.
Fig. 6
Fig. 6
(a) Percentage of days during the first two years of life that cohort children at each MAL-ED site received or did not receive antibiotics. (b) Treatment of diarrhea episodes with antibiotics at each MAL-ED site. Gray bars represent the percent of diarrhea episodes for which antibiotics were given. Black hash marks indicate the average number of antibiotics given.

References

    1. Lyte M. The microbial organ in the gut as a driver of homeostasis and disease. Med Hypoth. 2010;74:634–8.
    1. Aidy SE, Dinan TG, Cryan JF. Immune modulation of the brain-gut-microbe axis. Front Microbiol. 2014;5:146. doi: 10.3389/fmicb.2014.00146.
    1. Bakken JS. Staggered and tapered antibiotic withdrawal with administration of Kefir for recurrent Clostridium difficile infection. Clin Infect Dis. 2014;59:858–61.
    1. Heilpern D, Szilagyi A. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, prebiotics and synbiotics. Rev Recent Clin Trials. 2008;3:167–84.
    1. Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastro. 2006;40:264–9.
    1. Oberhelman RA, Gilman RH, Sheen P, Taylor DN, Black RE, Cabrera L, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr. 1999;134:15–20.
    1. Arvola T, Laiho K, Torkkeli S, Mykkänen H, Salminen S, Maunula L, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999;104:e64.
    1. Goldin BR, Gorbach SL. Clinical indications for probiotics: an overview. Clin Infect Dis. 2008;46:S96–100.
    1. Keusch GT, Rosenberg IH, Denno DM, Duggan C, Guerrant RL, Lavery JV, et al. Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food Nutr Bull. 2013;34:357–64.
    1. Korpe PS, Petri WA., Jr Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med. 2012;18:328–36.
    1. Prendergast A, Kelly P. Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg. 2012;86:756–63.
    1. Kosek M, Haque R, Lima A, Babji S, Shrestha S, Qureshi S, et al. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am. J Trop Med Hyg. 2013;88:390–6.
    1. Petri WA, Naylor C, Haque R. Environmental enteropathy and malnutrition: do we know enough to intervene? BMC Med. 2014;12:187–91.
    1. Lemon KP, Armitage GC, Relman DA, Fischbach MA. Microbiota-targeted therapies: an ecological perspective. Sci Transl Med. 2012;4:137rv5.
    1. Classen T, Boisson S, Routray P, Torondel B, Bell M, Cumming O, et al. Effectiveness of a rural sanitation programme on diarrhoea, soil-transmitted helminth infection, and child malnutrition in Odisha, India: a cluster-randomised trial. Lancet Glob Health. 2014;2:645–53.
    1. Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, Alam MA, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature. 2014;510:417–21.
    1. Kolling G, Wu M, Guerrant RL. Guerrant. Enteric pathogens through life stages. Front. Cell and Infect. Microbiol. 2012;2 doi: 10.3389/fcimb.2012.00114. art 114.
    1. MAL-ED Network Investigators. The malnutrition and enteric disease study (MAL-ED): understanding the consequences for child health and development. Clin Infect Dis. 2014;59:193–330.
    1. Caulfield LE, Bose A, Chandyo RK, Nesamvuni C, de Moraes ML, Turab A, et al. Infant feeding practices, dietary adequacy, and micronutrient status measures in the MAL-ED study. Clin Infect Dis. 2014;59:S248–54.
    1. Houpt E, Gratz J, Kosek M, Zaidi AK, Qureshi S, Kang G, et al. Microbiologic methods utilized in the MAL-ED cohort study. Clin Infect Dis. 2014;59:S225–32.
    1. Victora CG, Horta BL, Loret de Mola C, Quevedo L, Pinheiro RT, Gigante DP, et al. Association between breastfeeding and intelligence, educational attainment, and income at 30 years of age: a prospective birth cohort study from Brazil. Lancet Glob Health. 2015;3:e199–205.
    1. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107:14691–6.
    1. Rogawski ET, Westreich DJ, Sylvia Becker-Dreps S, Adair LS, Sandler RS, Sarkar R, et al. Antibiotic treatment of diarrhoea is associated with decreased time to the next diarrhoea episode among young children in Vellore, India. International Journal of Epidemiology. 2015:1–10. doi: 10.1093/ije/dyv040.

Source: PubMed

Подписаться